The Future’s Bright – the Future’s Biosimiliar
The first biosimilar was launched in 2006, but it is only now that the explosion of biosimilars into the market seems guaranteed. With the imminent or recent patent expiry of a range of biologics in oncology, rheumatoid arthritis and diabetes the scene is set for a dynamic influx of biosimilars that promise patients and healthcare...
Read More: The Future’s Bright – the Future’s Biosimiliar